LONDON (Reuters) - Batches of Sanofi-Aventis's blood-thinning heparin injection Lovenox have been found to contain small amounts of impurity in Britain, Sweden, Spain and Australia, officials said on ...

BETHLEHEM, Pa., July 18, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex ® IV bags.

CorMedix’s CRMD lead product, DefenCath (taurolidine plus heparin), is the company’s primary source of revenues. DefenCath ...

BALTIMORE - Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell receives a daily infusion of the drug in her bed at Johns ...

CorMedix CRMD took a major step to diversify its revenue base and lessen reliance on its lead marketed product, DefenCath (Taurolidine + Heparin), by acquiring Melinta Therapeutics for $300 million in ...

The FDA has continued to issue safety alerts and investigate events surrounding the injectable blood thinner heparin (FDA News, April 2008) and its “clear link” to 81 deaths in U.S. patients who ...

NEW YORK (Reuters) - B. Braun Medical Inc. on Friday said it is recalling 23 lots of its blood thinner after being notified by its supplier of a nationwide recall of Heparin Sodium USP because of a ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...